Featured Articles
July 15, 2021
Research on dapivirine ring use among adolescent girls and young women presented at IAS 2021
July 15, 2021—Interim results from REACH, an open-label study of IPM’s monthly dapivirine ring as well as of daily oral PrEP, are being presented at the 11th IAS Conference on HIV Science (IAS 2021... More »
March 17, 2021
Dapivirine Vaginal Ring Added to WHO Clinical Guidelines as HIV Prevention Choice for Women
March 17, 2021—The World Health Organization (WHO) has updated its clinical guidelines on antiretroviral (ARV) drugs for HIV prevention to include a recommendation for IPM’s monthly dapivirine... More »
March 08, 2021
By Women, For Women: An International Women's Day Story Collection
March 8, 2021—Happy International Women's Day! Here at IPM, women are at the core of everything we do—from developing woman-centered and woman-controlled HIV prevention and other sexual and... More »
March 05, 2021
Hope for the Future: My Experience With the Dapivirine Ring
March 5, 2021We spoke to Akhona Gxarisa, a 27-year-old primary school teacher in Cape Town, South Africa who participated in the Ring Study and DREAM. She tells us about her experience in the... More »
February 01, 2021
Dapivirine ring OLE study results featured in The Lancet HIV
February 1, 2021—Primary results from two open-label extension studies (OLEs) of IPM’s dapivirine vaginal ring, DREAM and HOPE, are featured in The Lancet HIV’s February 2021 issue. The publications... More »